Indication

Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

1 clinical trial

2 products

Clinical trial

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3): Beta Plus Study

Status: Recruiting, Estimated PCD: 2025-12-01

Product

Product